OPRC_Banner_Logo

ALERT BAR

Dates


Publications


Publications

  • Tacrolimus Placental Transfer at Delivery and Neonatal Exposure through Breast Milk

    Zheng, S., Easterling, T. R., Hays, K., Umans, J. G., Miodovnik, M., Clark, S., Calamia, J. C., Thummel, K. E., Shen, D. D., Davis, C. L., Hebert, M. F. (2013). Tacrolimus Placental Transfer at Delivery and Neonatal Exposure through Breast Milk. British Journal of Clinical Pharmacology, 76(6), 988-96. doi: 10.1111/bcp.12122. (PMID: 23528073)
  • Duration of cisplatin excretion in breast milk

    Hays, K. E., Ryu, R. J., Swisher, E. M., Reed, E., McManus, T., Rybeck, B., Petros, W. P., & Hebert, M. F. (2013). Duration of cisplatin excretion in breast milk. Journal of Human Lactation, 29(4), 469-72. doi: 10.1177/0890334413479671. (PMID: 23492761)
  • Transplacental transfer and distribution of pravastatin

    Nanovskaya, T. N., Patrikeeva, S. L., Paul, J., Costantine, M. M., Hankins, G. D., & Ahmed, M. S. (2013). Transplacental transfer and distribution of pravastatin. American Journal of Obstetrics and Gynecology, 209(4), 373.e1-5. doi: 10.1016/j.ajog.2013.05.038. (PMID: 24070396)
  • Reply: To PMID 23453884

    Caritis, S. N., Zhao, Y., Venkataramanan, R., & Bettinger, J. (2013). Reply: To PMID 23453884. American Journal of Obstetrics and Gynecology, 209(3), 285-6. doi: 10.1016/j.ajog.2013.04.038. (PMID: 23643571)
  • Quantitative determination of famotidine in human maternal plasma, umbilical cord plasma and urine using high-performance liquid chromatography-mass spectrometry

    Wang, X., Rytting, E., Abdelrahman, D. R., Nanovskaya, T. N., Hankins, G. D., & Ahmed, S. (2013). Quantitative determination of famotidine in human maternal plasma, umbilical cord plasma and urine using high-performance liquid chromatography-mass spectrometry. Biomedical Chromatography, 27(7), 866-73. doi: 10.1002/bmc.2873. (PMID: 23401067)
  • A Pharmacologic Approach to the Use of Glyburide in Pregnancy

    Caritis, S. N., & Hebert, M. F. (2013). A Pharmacologic Approach to the Use of Glyburide in Pregnancy. Obstetrics and Gynecology, 121(6), 1309-12. doi: 10.1097/AOG.0b013e31829007f0. (PMID: 23812467)
  • Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate

    Caritis, S. N., Zhao, Y., Bettinger, J., & Venkataramanan, R. (2013). Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate. American Journal of Obstetrics and Gynecology, 208(6), 470.e1-5. doi: 10.1016/j.ajog.2013.02.028. (PMID: 23453884)
  • A liquid chromatography method with single quadrupole mass spectrometry for quantitative determination of indomethacin in maternal plasma and urine of pregnant patients

    Wang, X., Vernikovskaya, D. I., Nanovskaya, T. N., Rytting, E., Hankins, G. D., & Ahmed, M. S. (2013). A liquid chromatography method with single quadrupole mass spectrometry for quantitative determination of indomethacin in maternal plasma and urine of pregnant patients. Journal of Pharmaceutical and Biomedical Analysis, 78-79, 123-8. doi: 10.1016/j.jpba.2013.02.006. (PMID: 23474812)
  • Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic

    Haas, D. M., Quinney, S. K., Clay, J., Renbarger, J. L., Hebert, M. F., Clark, S., Umans, J., & Caritis, S. N., for the Obstetric-Fetal Pharmacology Research Units Network (2013). Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. American Journal of Perinatology, 30(4), 275-81. doi: 10.1055/s-0032-1323590. (PMID: 22875663)
  • Interpreting tacrolimus concentrations during pregnancy and postpartum

    Hebert, M. F., Zheng, S., Hays, K., Shen, D. D., Davis, C. L., Umans, J. G., Miodovnik, M., Thummel, K. E., & Easterling, T. R. (2013). Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation, 95(7), 908-15. doi: 10.1097/TP.0b013e318278d367. (PMID: 23274970)
  • A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women

    Ke, A. B., Nallani, S. C., Zhao, P., Rostami-Hodjegan, A., Isoherranen, N., & Unadkat, J. D. (2013). A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women. Drug Metabolism and Disposition, 41(4), 801-13. doi: 10.1124/dmd.112.050161. (PMID: 23355638)
  • The impact of glucocorticoid polymorphisms on markers of neonatal respiratory disease after antenatal betamethasone administration

    Haas, D. M., Dantzer, J., Lehmann, A. S., Philips, S., Skaar, T. C., McCormick, C. L., Hebbring, S. J., Jung, J., & Li, L. (2013). The impact of glucocorticoid polymorphisms on markers of neonatal respiratory disease after antenatal betamethasone administration. American Journal of Obstetrics and Gynecology, 208(3), 215.e1-6. doi: 10.1016/j.ajog.2012.12.031. (PMID: 23295978)
  • Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy

    Matok, I., Clark, S., Caritis, S., Miodovnik, M., Umans, J., Hankins, G., & Koren, G. (2013). Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy. Journal of Clinical Pharmacology, 53(3), 334-8. doi: 10.1177/0091270012445207. (PMID: 23444286)
  • Pravastatin for the prevention of preeclampsia in high-risk pregnant women

    Costantine, M. M., Cleary, K., & Eunice Kennedy Shriver National Institute of Child Health and Human Development OPRU Network (2013). Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstetrics and Gynecology, 121(2 Pt 1), 349-53. doi: 10.1097/AOG.0b013e31827d8ad5. (PMID: 23344286)
  • A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS

    Pillai, V. C., Strom, S. C., Caritis, S. N., & Venkataramanan, R. (2013). A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 74, 126-32. doi: 10.1016/j.jpba.2012.10.016. (PMID: 23245243)
  • Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: A comparison with adult human hepatocytes

    Sharma, S., Ellis, E. C., Gramignoli, R., Dorko, K., Tahan, V., Hansel, M., Mattison, D. R., Caritis, S. N., Hines, R. N., Venkataramanan, R., & Strom, S. C. (2013). Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: A comparison with adult human hepatocytes. Drug Metabolism and Disposition, 41(2), 296-304. doi: 10.1124/dmd.112.044891. (PMID: 23129211)
  • Effect of endogenous steroid hormones on 17-alpha-hydroxyprogesterone caproate metabolism

    Cuppett, C. D., Zhao, Y., Caritis, S., Zhang, S., Zhao, W., & Venkataramanan, R. (2013). Effect of endogenous steroid hormones on 17-alpha-hydroxyprogesterone caproate metabolism. American Journal of Obstetrics and Gynecology, 208(1), 86.e1-6. doi: 10.1016/j.ajog.2012.09.021. (PMID: 23063018)
  • Antenatal thyroid disease and pharmacotherapy in pregnancy

    Clark, S. N., & Hankins, G. D. (2013). Antenatal thyroid disease and pharmacotherapy in pregnancy. In D. Mattison (Ed.), Clinical pharmacology in pregnancy. London, UK: Elsevier.
  • Pharmacogenomics in pregnancy

    Haas, D. M., & Flockhart, D. A. (2013). Pharmacogenomics in pregnancy. In D. R. Mattison (Ed.), Clinical pharmacology during pregnancy (pp. 113-128). London, UK: Elsevier, Inc.
  • Impact of pregnancy on maternal pharmacokinetics of medications

    Hebert, M. F. (2013). Impact of pregnancy on maternal pharmacokinetics of medications. In D. R. Mattison (Ed.), Clinical pharmacology during pregnancy. London, Elsevier, Inc.
  • Fetal drug therapy

    Rytting, E., & Ahmed, M. S. (2013). Fetal drug therapy. In D. R. Mattison (Ed.), Clinical pharmacology during pregnancy. London, UK: Elsevier, Inc.